Immunotherapy of insulin-dependent diabetes mellitus

被引：19

作者：

Bach, JF ^{[1
]}

机构：

[1] Hop Necker Enfants Malad, INSERM, U25, F-75743 Paris 15, France

来源：

CURRENT OPINION IN IMMUNOLOGY | 2001年 / 13卷 / 05期

关键词：

D O I：

10.1016/S0952-7915(00)00267-3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Immunotherapy of diabetes is now focusing on induction of tolerance to beta cell antigens using either soluble antigens or monoclonal anti-T-cell antibodies. These approaches have reached the clinical arena. At the experimental level, strategies are being developed that use or target cytokines (with gene therapy) or stimulate regulatory T cells.

引用

页码：601 / 605

页数：5

共 56 条

[41] B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes [J].

Salomon, B ;

Lenschow, DJ ;

Rhee, L ;

Ashourian, N ;

Singh, B ;

Sharpe, A ;

Bluestone, JA .

IMMUNITY, 2000, 12 (04) :431-440

[42] ANTI-ALPHA/BETA T-CELL RECEPTOR MONOCLONAL-ANTIBODY PROVIDES AN EFFICIENT THERAPY FOR AUTOIMMUNE DIABETES IN NONOBESE DIABETIC (NOD) MICE [J].

SEMPE, P ;

BEDOSSA, P ;

RICHARD, MF ;

VILLA, MC ;

BACH, JF ;

BOITARD, C .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (05) :1163-1169

[43] Interferon-γ receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice [J].

Serreze, DV ;

Post, CM ;

Chapman, HD ;

Johnson, EA ;

Lu, BF ;

Rothman, PB .

DIABETES, 2000, 49 (12) :2007-2011

[44] Th1 to Th2 cytokine shifts in nonobese diabetic mice: Sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation [J].

Serreze, DV ;

Chapman, HD ;

Post, CM ;

Johnson, EA ;

Suarez-Pinzon, WL ;

Rabinovitch, A .

JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :1352-1359

[45] THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].

SHAMOON, H ;

DUFFY, H ;

FLEISCHER, N ;

ENGEL, S ;

SAENGER, P ;

STRELZYN, M ;

LITWAK, M ;

WYLIEROSETT, J ;

FARKASH, A ;

GEIGER, D ;

ENGEL, H ;

FLEISCHMAN, J ;

POMPI, D ;

GINSBERG, N ;

GLOVER, M ;

BRISMAN, M ;

WALKER, E ;

THOMASHUNIS, A ;

GONZALEZ, J ;

GENUTH, S ;

BROWN, E ;

DAHMS, W ;

PUGSLEY, P ;

MAYER, L ;

KERR, D ;

LANDAU, B ;

SINGERMAN, L ;

RICE, T ;

NOVAK, M ;

SMITHBREWER, S ;

MCCONNELL, J ;

DROTAR, D ;

WOODS, D ;

KATIRGI, B ;

LITVENE, M ;

BROWN, C ;

LUSK, M ;

CAMPBELL, R ;

LACKAYE, M ;

RICHARDSON, M ;

LEVY, B ;

CHANG, S ;

HEINHEINEMANN, M ;

BARRON, S ;

ASTOR, L ;

LEBECK, D ;

BRILLON, D ;

DIAMOND, B ;

VASILASDWOSKIN, A ;

LAURENZI, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986

[46] ALTERED CYTOKINE ACTIVITY IN ADJUVANT INHIBITION OF AUTOIMMUNE DIABETES [J].

SHEHADEH, NN ;

LAROSA, F ;

LAFFERTY, KJ .

JOURNAL OF AUTOIMMUNITY, 1993, 6 (03) :291-300

[47] Increased β-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse [J].

Sreenan, S ;

Pick, AJ ;

Levisetti, M ;

Baldwin, AC ;

Pugh, M ;

Polonsky, KS .

DIABETES, 1999, 48 (05) :989-996

[48] Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice [J].

Tian, JD ;

ClareSalzler, M ;

Herschenfeld, A ;

Middleton, B ;

Newman, D ;

Mueller, R ;

Arita, S ;

Evans, C ;

Atkinson, MA ;

Mullen, Y ;

Sarvetnick, N ;

Tobin, AJ ;

Lehmann, PV ;

Kaufman, DL .

NATURE MEDICINE, 1996, 2 (12) :1348-1353

[49]

Tisch R, 1999, J IMMUNOL, V163, P1178

[50] Antigen-specific mediated suppression of β cell autoimmunity by plasmid DNA vaccination [J].

Tisch, R ;

Wang, B ;

Weaver, DJ ;

Liu, S ;

Bui, T ;

Arthos, J ;

Serreze, DV .

JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :2122-2132

← 1 2 3 4 5 6 →